Burkhart Erin
Insider CIK 1927648 · BMRN GVP, Chief Accounting Officer · GILD SVP, Controllership
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-09-22 | 2026-09-23 | 2,223 | — | $0 | 9,022 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-09-22 | 2026-09-23 | 2,223 | — | $0 | 2,223 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-09-22 | 2026-09-23 | 768 | $152.67 | $117.3K | 1,455 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise deriv | 2026-09-22 | 2026-09-23 | 2,223 | — | — | 9,022 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | F Tax w/h | 2026-09-22 | 2026-09-23 | 768 | $152.67 | $117.3K | 1,455 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | M Exercise | 2026-09-22 | 2026-09-23 | 2,223 | — | — | 2,223 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 5,455 | — | $0 | 5,455 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 2,355 | — | $0 | 11,245 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2025-09-22 | 2025-09-23 | 8,890 | — | $0 | 8,890 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2025-05-20 | 2025-05-20 | 1,786 | $59.31 | $105.9K | 14,173 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-05-19 | 2025-05-20 | 996 | $59.27 | $59.0K | 15,959 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2025-03-19 | 2025-03-20 | 1,295 | $71.52 | $92.6K | 16,955 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2025-03-17 | 2025-03-18 | 9,230 | — | $0 | 9,230 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-03-17 | 2025-03-18 | 5,970 | — | $0 | 18,252 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-03-14 | 2025-03-18 | 823 | $69.44 | $57.1K | 12,282 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2025-02-24 | 2025-02-25 | 1,344 | $68.38 | $91.9K | 13,105 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-08-13 | 2024-08-15 | 714 | $90.00 | $64.3K | 14,449 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-05-17 | 2024-05-20 | 993 | $76.97 | $76.4K | 15,163 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-04-10 | 2024-04-12 | 2,286 | $90.00 | $205.7K | 16,156 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-18 | 2024-03-19 | 372 | $83.87 | $31.2K | 18,442 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 7,050 | — | $0 | 7,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 4,720 | — | $0 | 18,814 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-05-16 | 2023-05-18 | 796 | $92.02 | $73.2K | 14,094 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 5,720 | — | $0 | 5,720 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 3,760 | — | $0 | 14,890 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-05-16 | 2022-05-18 | 17,490 | — | $0 | 17,490 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-05-16 | 2022-05-18 | 11,130 | — | $0 | 11,130 | SEC↗ |